Formosa Pharmaceuticals and AimMax Therapeutics Announce Successful Top-Line Results from CPN-301 for the Treatment of Inflammation and Pain after Cataract Surgery

Formosa Pharmaceuticals And Aimmax Therapeutics Announce Successful Top Line Results From Cpn 301 For The Treatment Of Inflammation And Pain After Cataract Surgery

Facebook Comments

Leave a Reply

CommentLuv badge